Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GS 0573 is an experimental small molecule antiviral compound belonging to the class of organic compounds known as 6-aminopurines. Its chemical formula is C8H13N6O4P and it has a molecular weight of approximately 288.20 g/mol. The compound has been studied primarily for its potential use in the treatment of Feline herpesvirus type 1 (FHV-1), a significant pathogen in cats[1][4][8]. The mechanism of action is not fully elucidated but, as a purine analogue with phosphonate modification, it likely acts by inhibiting viral DNA polymerase or interfering with viral replication pathways similar to other nucleoside/nucleotide analogues[4]. It is not approved for human use and remains at the research stage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on GS 0573.